Published in Hautarzt on April 01, 1995
Analysis of apoptosis during hair follicle regression (catagen) Am J Pathol (1997) 1.82
IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol (1993) 2.44
Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol (1995) 1.54
Mast cells. Int J Dermatol (1995) 1.52
Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol (1995) 1.50
Human mast cells produce IL-8. J Immunol (1993) 1.44
[Recurrent nodular panniculitis in alpha 1-antitrypsin deficiency. Successful dapsone therapy]. Hautarzt (1993) 1.39
Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol (1994) 1.34
Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am J Pathol (1994) 1.30
Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187. J Immunol (1976) 1.27
Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. FASEB J (2000) 1.26
Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis. J Immunol (1976) 1.22
A murine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporin A. J Invest Dermatol (1994) 1.18
Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol (1994) 1.18
Electron microscopical evidence for a direct contact between nerve fibres and mast cells. Acta Derm Venereol (1981) 1.15
Leukotriene B4 induces in vitro fibroblast chemotaxis. J Invest Dermatol (1984) 1.13
Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors. Cancer Res (2001) 1.09
Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol (1994) 1.08
Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours. J Pathol (1993) 1.08
Mast cell involvement in murine hair growth. Dev Biol (1994) 1.06
Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice. Cancer Res (1996) 1.02
Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch Dermatol Res (1994) 1.02
A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells. Cancer Res (1997) 0.99
Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res (1994) 0.98
In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B4 and its w-oxidation products. Prostaglandins (1985) 0.98
Demonstration of the high-affinity IgE receptor on human Langerhans cells in normal and diseased skin. Br J Dermatol (1993) 0.97
Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med (1995) 0.97
Patterns of cell death: the significance of apoptosis for dermatology. Exp Dermatol (1993) 0.96
Hair growth induction by substance P. Lab Invest (1994) 0.96
Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin. J Invest Dermatol (1984) 0.95
Chemotaxis of human neutrophils and eosinophils towards leukotriene B4 and its 20-w-oxidation products in vitro. Prostaglandins (1986) 0.95
Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1). J Invest Dermatol (1994) 0.94
Biological and chemical characterization of eosinophil chemotactic factors from human leukocytes. Agents Actions Suppl (1983) 0.93
Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst (1995) 0.92
Chemotactic leukotrienes in psoriasis. Lancet (1982) 0.92
Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate. Br J Dermatol (1981) 0.91
Distribution and changing density of gamma-delta T cells in murine skin during the induced hair cycle. Br J Dermatol (1994) 0.91
Substance P stimulates murine epidermal keratinocyte proliferation and dermal mast cell degranulation in situ. Arch Dermatol Res (1995) 0.91
P-glycoprotein expression in primary and metastatic malignant melanoma. Br J Dermatol (1995) 0.91
Ultrastructure of inclusions in peripheral blood mononuclear cells in sarcoidosis. Am J Pathol (1975) 0.91
Topical treatment of multiple actinic keratoses of the face with arotinoid methyl sulfone (Ro 14-9706) cream versus tretinoin cream: a double-blind, comparative study. J Am Acad Dermatol (1991) 0.90
In vitro generation of mast cell-like cells from human peripheral mononuclear phagocytes. Int Arch Allergy Appl Immunol (1983) 0.90
Evidence that water acts as a carrier for an epidermal antigen in aquagenic urticaria. J Am Acad Dermatol (1986) 0.90
Effect of 1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) on leukocytes I. Analysis of the in vitro migration of human neutrophils. Chem Phys Lipids (1981) 0.90
Glucocorticoid-induced modulation of cytokine secretion from normal and leukemic human myelomonocytic cells. Int Arch Allergy Immunol (1996) 0.90
Morphology of the cellular infiltrate in delayed pressure urticaria. J Am Acad Dermatol (1985) 0.89
Mast cells as modulators of hair follicle cycling. Exp Dermatol (1995) 0.89
Foreign-body granuloma and IgE-pseudolymphoma after multiple bee stings. Br J Dermatol (1994) 0.89
Development of human connective tissue mast cells from purified blood monocytes. Immunology (1984) 0.89
Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline. Acta Derm Venereol (1995) 0.89
Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs. J Invest Dermatol (1998) 0.89
Studies on the role of leukotrienes in murine allergic and irritant contact dermatitis. Br J Dermatol (1988) 0.88
Detection of human papillomaviruses in paraffin-embedded condylomata acuminata--comparison of immunohistochemistry, in situ hybridization, and polymerase chain reaction. J Invest Dermatol (1991) 0.88
Characterization of gene regulatory elements for selective gene expression in human melanoma cells. Biochem Biophys Res Commun (1995) 0.88
Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models. Clin Cancer Res (1998) 0.88
Monoclonal antibodies to leucosialin (CD43) induce homotypic aggregation of the human mast cell line HMC-1: characterization of leucosialin on HMC-1 cells. Immunology (1994) 0.87
[New perspectives in hair research: in search of the "biological clock" of the hair cycle]. Hautarzt (1992) 0.87
Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes. Arch Dermatol Res (1984) 0.87
Primary leiomyosarcoma of the skin. A histological and immunohistochemical analysis. Acta Derm Venereol (1993) 0.86
Clinical, pharmacological and immunological aspects of delayed pressure urticaria. Br J Dermatol (1984) 0.86
In vitro differentiation of rat peritoneal macrophages into mast cells: an enzymecytochemical study. Blut (1982) 0.86
Interleukin-6 expression in the skin of patients with lupus erythematosus. Exp Dermatol (1995) 0.86
Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies. Dermatologica (1988) 0.85
Correlation of proteolytic activities of organ cultured intact mouse skin with defined hair cycle stages. J Dermatol Sci (1994) 0.85
Expression of stem cell factor in cutaneous mastocytosis. Br J Dermatol (1995) 0.85
Production of LTB4-like chemotactic arachidonate metabolites from human keratinocytes. J Invest Dermatol (1985) 0.85
Nerve growth factor modulates keratinocyte proliferation in murine skin organ culture. Br J Dermatol (1994) 0.85
Expression of classical and non-classical MHC class I antigens in murine hair follicles. Br J Dermatol (1994) 0.85
Comparative studies on eosinophil chemotactic factors during leukocyte migration under agarose. J Invest Dermatol (1982) 0.84
Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations. J Invest Dermatol (1984) 0.84
Eosinophils chemotactic factor (ECF). IV. Inhibitory activity in human peripheral leukocytes. Int Arch Allergy Appl Immunol (1978) 0.84
Amelanotic malignant melanoma presenting as malignant schwannoma. Br J Dermatol (1993) 0.83
Eosinophil chemotactic factor (ECF). III. Generation in human peripheral leukocytes. Int Arch Allergy Appl Immunol (1978) 0.83
Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity. Cancer (1994) 0.83
Restoration of membrane TNF-like activity by cell surface targeting and matrix metalloproteinase-mediated processing of a TNF prodrug. Cell Death Differ (2006) 0.83
[Annular elastolytic giant cell granuloma with a spontaneous healing tendency]. Hautarzt (1995) 0.83
Expression of growth factor receptors on human melanoma cells: comparison of modulating effects of interferons and retinoids. Exp Dermatol (1993) 0.82
Mast cells in melanocytic tumours. Arch Dermatol Res (1995) 0.82
In vitro generation of eosinophil chemotactic factor from human and murine mononuclear phagocytes. Scand J Immunol (1981) 0.82
A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa. Dermatologica (1983) 0.82
Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma. J Cancer Res Clin Oncol (1979) 0.82
The differentiation-related upregulation of aryl hydrocarbon receptor transcript levels is suppressed by retinoic acid. Biochem Biophys Res Commun (1995) 0.82
Histamine releasability of basophils and skin mast cells in chronic urticaria. Allergy (1996) 0.81
Efficacy of cetirizine in cholinergic urticaria. Acta Derm Venereol (1995) 0.81
Plasmapheresis in severe drug-induced toxic epidermal necrolysis. Arch Dermatol (1985) 0.81
Neutrophil-derived eosinophil chemotactic factor production induced by immune complexes. Int Arch Allergy Appl Immunol (1981) 0.81
[Pregnancy after malignant melanoma. A follow-up of 23 patients]. Dtsch Med Wochenschr (1985) 0.81
[Biology of the hair follicle]. Hautarzt (1994) 0.81
Ketotifen in cholinergic urticaria. J Allergy Clin Immunol (1990) 0.81
Progesterone withdrawal up-regulates vascular endothelial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: potential relevance to menstruation. J Clin Endocrinol Metab (2000) 0.81
Interferon-gamma downregulates epidermal growth factor receptors on human melanoma cells. Exp Dermatol (1995) 0.81
Multiple (subcutaneous) angiolipomas. Clinical, pathologic, and pharmacologic studies. Arch Dermatol (1974) 0.81
Modulation of eosinophil chemotaxis and eosinophil chemotactic factor release by concanavalin A. Int Arch Allergy Appl Immunol (1978) 0.81
Serum manganese superoxide dismutase is a new tumour marker for malignant melanoma. Melanoma Res (1995) 0.80
Cytokine secretion by human mast cells. Exp Dermatol (1995) 0.80
Extramammary Paget's cells: further evidence of sweat gland derivation. J Am Acad Dermatol (1986) 0.80
Glutathione and related enzymes in tumor progression and metastases of human melanoma. J Invest Dermatol (1995) 0.80
Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter. Br J Cancer (1995) 0.80
Establishment and characterization of a cell line (Wa-2) derived from an extrarenal rhabdoid tumor. Cancer Res (1990) 0.80